Global Incretin-Based Drugs Market, 2016–2024

nancymoore

The key factors that are driving the incretin-based drugs market are rising old age population, increased rate of obesity, sedentary lifestyle, increasing rate of people suffering from cardiovascular diseases and diabetes, and the increasing awareness among the people.

Published By:Zion Market Research

Incretin-Based Drugs Market: By Type, Application, Size, Growth, Analysis

& Forecast 2024

Contact Us:

4283, Express Lane, Suite 634-143,

Sarasota, Florida 34249, United States

Tel: +1-386-310-3803 GMT

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

sales@zionmarketresearch.com


Incretin-Based Drugs Market

Global Incretin-Based Drugs Market: Overview

When the blood glucose levels decrease a group of metabolic hormones is stimulated which

is known as incretins. Incretin-based drugs include glucagon-like peptide-1 receptor

agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors which are the new group of drugs

that are helpful in curing type 2 diabetes. These drugs have a positive effect on the body

weight and have a low risk of hypoglycemia. The oral anti-diabetic drugs are unable to

maintain the desired levels of glucose, especially during the conditions of postprandial, thus

increasing the requirement for a better therapeutics such as the incretin-based drugs. The

consumption of the incretin-based drugs increases the secretion of insulin and inhibits the

release of glucagon.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/incretinbased-drugs-market

Global Incretin-Based Drugs Market: Segmentation

The global market for the incretin-based drugs is fragmented into its drug type, formulation,

and distribution channel. Depending on the drug type, the global market is segregated into

dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor (GLP-1)

agonists. Depending on the formulation, the market is categorized into injectable drugs and

oral drugs. Depending on the distribution channel, the market is divided into online

pharmacies, hospital pharmacies, retail pharmacies, and others.


Incretin-Based Drugs Market

Global Incretin-Based Drugs Market: Growth Factors

The key factors that are driving the incretin-based drugs market are rising old age

population, increased rate of obesity, sedentary lifestyle, increasing rate of people suffering

from cardiovascular diseases and diabetes, and the increasing awareness among the

people. The other factor that is driving the growth of the market is the rise in the number of

patients that are undiagnosed and pre-diagnosed for the disease. There are certain factors

that will restrain the growth of the market which include the absence of supportive

reimbursement policies, lack of accessibility to the drugs, a high cost that is involved in the

treatment and the increased safety concerns affect the market growth negatively.

Request Report TOC (Table of Contents) @

https://www.zionmarketresearch.com/toc/incretin-based-drugs-market

Global Incretin-Based Drugs Market: Regional Analysis

According to the regional study, the global market for the incretin-based drugs is diversified

into Eastern Europe, North America, Western Europe, Asia Pacific, the Middle East and

Africa, and Latin America. There is an increased demand for the incretin-based drugs in the

Asia Pacific region. While North America and Western European region are considered as

lucrative markets for the incretin-based drugs due to the increased awareness about

diabetes and the good management of the disease. The growth of the incretin-based drugs

market is majorly influenced by the supportive policies that are implemented by the

government. In many of the countries, the governments are providing support to the weaker

sections of the society to have the access to the diabetes drugs so that they have access to

quality healthcare.


Incretin-Based Drugs Market

Browse detail report @ https://www.zionmarketresearch.com/report/incretin-based-drugsmarket

Global Incretin-Based Drugs Market: Competitive Players

The key market players that are involved in the incretin-based drugs market include

Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., Merck & Co., Inc., Takeda

Pharmaceutical Company Ltd., Sanofi S.A., AstraZeneca Plc., Eli Lilly and Company,

Johnson & Johnson, and Novartis AG.

Inquire more before buying this report @

https://www.zionmarketresearch.com/inquiry/incretin-based-drugs-market

Zion Market Research

Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States

Tel: +1-386-310-3803 GMT

+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)

Email: sales@zionmarketresearch.com

Web:www.zionmarketresearch.com

More magazines by this user
Similar magazines